Immunohistochemistry studies of serial sections demonstrated expression of both matriptase and c-Met in infiltrating cancer cells and in the cancer cells of lymphatic emboli in the majority of IBC patients. This evidence concerns the gene MET and inflammatory breast carcinoma.